Biologic therapies in type 1 diabetes: how far are they from us?
- Author:
Chao DENG
1
;
Yu-Fei XIANG
;
Zhi-Guang ZHOU
Author Information
1. Diabetes Center, Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Key Laboratory of Diabetes Immunology, Ministry of Education, Central South University, Changsha, Hunan 410011, China.
- Publication Type:Editorial
- MeSH:
Abatacept;
Antibodies, Monoclonal, Humanized;
therapeutic use;
Antibodies, Monoclonal, Murine-Derived;
therapeutic use;
Biological Therapy;
methods;
Diabetes Mellitus, Type 1;
drug therapy;
Humans;
Immunoconjugates;
therapeutic use;
Rituximab
- From:
Chinese Medical Journal
2013;126(21):4003-4005
- CountryChina
- Language:English
